Randomized Trial of Peginterferon Alfa-2b and Ribavirin for 48 or 72 Weeks in Patients With Hepatitis C Virus Genotype 1 and Slow Virologic Response
Hepatology - United States
doi 10.1002/hep.23816
Full Text
Open PDFAbstract
Available in full text
Date
August 3, 2010
Authors
Publisher
Wiley